OTC · Drug Manufacturers - Specialty & Generic

Cann American Corp. (CNNA) Stock

$0.01 +8.33% OTC: CNNA Healthcare

Cann American Corp. is an early-stage enterprise dedicated to developing specialized Cannabis sativa varieties designed for animal consumption.

Valuation

MetricValue
Price$0.01
Market Cap$4.80M
P/E Ratio0.53
P/B Ratio-0.72
P/S Ratio0.00
EPS (TTM)$0.02
52-Week High$0.01
52-Week Low$0.00
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-80.82%
ROA—
ROCE5.16%
Gross Margin0.00%
Operating Margin0.00%
Net Margin0.00%
Debt/Equity-0.13
Current Ratio0.02

Annual Financials (USD)

Metric20172018201920212022
Revenue$0$0$0$0$0
Operating Profit$0$0$0$0$0
Net Profit$0$0$0$0$0
EPS$0.00$0.00$0.00$0.04$0.01
Op Margin-2.0%-6.4%-54.0%——

Balance Sheet (USD)

Metric20172018201920212022
Total Assets$0$0$0$0$0
Total Liabilities$0$0$0$0$0
Cash$0$0$0$0$0
Borrowings$0$0$0$0$0

Cash Flow (USD)

Metric20172018201920212022
Operating Cash Flow$0$0$0$0$0
Investing Cash Flow$0$0$0$0$0
Financing Cash Flow$0$0$0$0$0
Net Cash Flow$0$0$0$0$0
Free Cash Flow$0$0$0$0$0

Valuation & Return Ratios

MetricValue
PEG Ratio0.00
EV / EBITDA0.00
FCF Yield0.00%
Quick Ratio0.02
Interest Coverage—
Return 1Y215.79%
Return 3Y500.00%
Return 5Y—

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
ALIDAllied Corp. $0.00 — 0.00 $57748 0.00%
APPBApplied Biosciences Corp. $0.00 — 0.00 $1365 0.00%
CBDYTarget Group Inc. $0.00 — -0.41 $740431 0.00%
CPMDCannaPharmaRX, Inc. $0.00 — -0.13 $1.42M 0.00%
ENZCEnzolytics Inc. $0.00 — -11.20 $2.36M 0.00%

About Cann American Corp.

Cann American Corp. is an early-stage enterprise dedicated to developing specialized Cannabis sativa varieties designed for animal consumption. The company's strategic focus is on markets within various European Union countries. Established in 2004 and headquartered in Cloverdale, California, Cann American Corp. previously operated as Canamed4Pets, Inc. before officially rebranding in December 2019.

Cann American Corp. is headquartered in US.

Cann American Corp. (CNNA) stock trades at $0.01 with a market capitalization of $4.80M. The stock is valued at a price-to-earnings (P/E) ratio of 0.53, a negative price-to-book of -0.72, reflecting negative shareholders' equity, price-to-sales of 0.00. Over the past 52 weeks the stock has ranged between $0.00 and $0.01, and currently trades at or near its 52-week high.

On profitability, Cann American Corp. generates a return on equity (ROE) of -80.82% (not meaningful, as shareholders' equity is negative), return on capital employed of 5.16%.

Official website: www.cnnacorp.com

Related Healthcare Stocks

LLY Eli Lilly and Company $1179.27 +0.83% JNJ Johnson & Johnson $261.44 +1.93% ABBV AbbVie Inc. $276.47 +1.49% MRK Merck & Company, Inc. Common Stock (new) $145.60 +2.26% UNH UnitedHealth Group Incorporated Common Stock (DE) $379.30 +2.25% NVS Novartis AG $143.75 +0.45% AZN AstraZeneca PLC $159.20 +0.26% TMO Thermo Fisher Scientific Inc $658.02 +0.93% AMGN Amgen Inc. $414.87 +1.82% GILD Gilead Sciences, Inc. $151.17 +2.77% ABT Abbott Laboratories $99.60 +1.13% NVO Novo Nordisk A/S $38.64 +1.20%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Related stock screens

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksAll stock screens
Run Stock Screener Investing Guides

Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.